Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial.
Elizabeth A MagnusonHaiyan LiKatherine VilainDamianos G KokkinidisEric A SecemskyStefanos GiannopoulosGeorge L AdamsJihad A MustaphaDavid Joel Cohennull nullPublished in: Journal of medical economics (2021)
Among patients with symptomatic lower extremity PAD undergoing endovascular revascularization, initial treatment costs and total 2-year costs vary significantly according to clinical and lesion-level characteristics, as well as symptom burden.
Keyphrases
- patients undergoing
- healthcare
- percutaneous coronary intervention
- coronary artery bypass grafting
- study protocol
- phase iii
- risk factors
- aortic dissection
- coronary artery disease
- acute coronary syndrome
- combination therapy
- replacement therapy
- patient reported
- smoking cessation
- open label
- health insurance
- drug induced